Cyfuse Biomedical K.K.

Tokyo Stock Exchange 4892.T

Cyfuse Biomedical K.K. Market Capitalization on January 30, 2025: USD 24.85 M

Cyfuse Biomedical K.K. Market Capitalization is USD 24.85 M on January 30, 2025, a -35.42% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.
  • Cyfuse Biomedical K.K. 52-week high Market Capitalization is USD 38.83 M on July 31, 2024, which is 56.25% above the current Market Capitalization.
  • Cyfuse Biomedical K.K. 52-week low Market Capitalization is USD 22.65 M on December 23, 2024, which is -8.84% below the current Market Capitalization.
  • Cyfuse Biomedical K.K. average Market Capitalization for the last 52 weeks is USD 29.53 M.
Key data
Date Market Capitalization Share Price Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S)
Market news
SV Wall Street
Tokyo Stock Exchange: 4892.T

Cyfuse Biomedical K.K.

CEO Ms. Shizuka Akieda
IPO Date Dec. 1, 2022
Location Japan
Headquarters Sumitomo Fudosan Mita Twin Building
Employees 21
Sector Health Care
Industries
Biotechnology Pharmaceuticals
Description

Cyfuse Biomedical K.K. engages in the development, manufacture, and sale of regenerative medicine products in Japan. It develops cellular products in the field of regenerative therapy; and undertakes contract for cellular products for research and development. The company also offers Bio 3D Printer for use in the regeneration of various tissues and organs, such as cartilage and bones, blood vessels, and nerves; regenova, a bio 3D printer for 3D stacking of cells; and S-PIKE that develops 3D-structures from cells. Cyfuse Biomedical K.K. was incorporated in 2010 and is based in Tokyo, Japan.

StockViz Staff

January 31, 2025

Any question? Send us an email